Mirum Pharmaceuticals (MIRM) SEC Filings & 10K Form

$25.84
+0.24 (+0.94%)
(As of 05/3/2024 ET)

Recent Mirum Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/23/2024
3:20 PM
Mirum Pharmaceuticals (Filer)
Form DEF 14A
04/23/2024
3:21 PM
Mirum Pharmaceuticals (Filer)
Form DEFA14A
03/27/2024
7:47 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:41 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:44 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:46 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:34 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:37 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:40 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:32 PM
Mirum Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/15/2024
4:03 PM
Mirum Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2024
3:05 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
11:49 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G/A
02/05/2024
8:04 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
8:05 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
8:10 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
8:12 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
8:28 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G
01/25/2024
6:10 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:10 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
6:39 PM
Mirum Pharmaceuticals (Issuer)
Quan Joanne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/18/2024
6:42 PM
Mirum Pharmaceuticals (Issuer)
Quan Joanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:21 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:25 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:28 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:09 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:12 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
7:30 AM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
4:16 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
7:14 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
7:11 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
7:13 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
3:15 PM
Mirum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2023
3:39 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
3:47 PM
Mirum Pharmaceuticals (Filer)
Form S-3ASR
10/13/2023
3:16 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Gold Mania (Ad)

Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).

See his free reveal right here.
09/18/2023
3:35 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G
09/15/2023
3:56 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
6:33 PM
GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
4:06 PM
GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:39 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
5:21 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2023
5:23 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
3:16 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
4:25 PM
Mirum Pharmaceuticals (Subject)
O'Donnell Niall (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
2:11 PM
Frazier Life Sciences IX, L.P. (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13D/A
09/05/2023
11:51 AM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
7:36 AM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2023
3:15 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2023
3:30 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
5:16 AM
Mirum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2023
7:16 AM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
6:47 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
6:30 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
6:33 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
6:35 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
6:37 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
1:32 PM
Mirum Pharmaceuticals (Subject)
New Enterprise Associates 16, L.P. (Filed by)
Form SC 13D/A
06/15/2023
3:31 PM
Florence Anthony A. Jr. (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:34 PM
Makhzoumi Mohamad (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:35 PM
Mirum Pharmaceuticals (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:36 PM
Mirum Pharmaceuticals (Issuer)
Walker Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:22 PM
Mirum Pharmaceuticals (Issuer)
New Enterprise Associates 16, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:24 PM
Mirum Pharmaceuticals (Issuer)
NEA 16 GP, LLC (Reporting)
NEA Partners 16, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:26 PM
BASKETT FOREST (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:28 PM
Behbahani Ali (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:29 PM
Chang Carmen (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:54 PM
Mirum Pharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:56 PM
Cardon Lon (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
5:00 PM
Mirum Pharmaceuticals (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:40 PM
Fischer Laurent (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:45 PM
Brege Laura (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:47 PM
Fairey William (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:35 PM
GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:38 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:02 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2023
4:37 PM
GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/04/2023
8:58 PM
GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MIRM) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners